About: SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases in the United States. Its lead product candidate is SAB-142, a potentially disease-modifying and redosable immunotherapy in clinical development for the treatment of autoimmune type 1 diabetes in Phase 2b clinical trials. The company was founded in 2014 and is headquartered in Miami Beach, Florida.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.80 (-1.06%)
SABS NASDAQ SAB Biotherapeutics Inc
SAB Biotherapeutics Inc share price
SABS price activity
Last Price
$2.800
Change (24hr)
-0.03 USD (-1.06%)
Volume
133.44K
Volume (4w avg)
-
Open
$2.85
Day Range
$2.80 - $2.85
Previous Close
$2.83
Last Trade
13 Oct, 4:24 pm GMT+0
Delayed
13 Oct, 4:24 pm GMT+0
SABS price performance
Delayed
13 Oct, 4:24 pm GMT+0
SABS Market Signals